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INTRODUCTION
In 2004, the National Task Force on Fetal Alcohol 
Syndrome and Fetal Alcohol Effect, coordinated by the 
Centers for Disease Control and Prevention’s National 
Center on Birth Defects and Developmental Disabilities, 
established a working group committed to addressing the 
needs of individuals living with fetal alcohol spectrum 
disorders (FASDs) and their families. The culmination 
of this working group’s discussions and Task Force 
deliberations is reflected in this Call to Action report. 
The document highlights ten recommendations to 
improve and expand efforts regarding early identification, 
diagnostic services, and quality research on interventions 
for individuals with FASDs and their families. Additional 
background information is provided to support these 
recommendations and to further educate readers on the 
topic of FASDs, progress to date, and what still needs to 
be done to support individuals with FASDs. The intent 
of this report is to guide federal, state and local agencies, 
researchers and clinicians, family support groups, and 
other partners on actions needed to advance essential 
services for individuals with FASDs and their families and 
to promote continued intervention research efforts.
A CALL TO ACTION 
Fetal alcohol spectrum disorders (FASDs) 
are serious, lifelong birth defects and developmental 
disabilities caused by prenatal alcohol exposure. They 
are 100% preventable. Still, a surprisingly large number 
of children are born with FASDs each year. 
FASDs are a public health problem we must face. The U.S. 
Surgeon General has stated clearly that no amount of alcohol 
consumption can be considered safe for a pregnant woman 
and that alcohol can damage a fetus at any stage of pregnancy 
(Office of the Surgeon General, 2005). Yet, recent U.S. surveys 
reveal that approximately 12% of pregnant women still drink 
alcohol (CDC, 2004; SAMHSA, 2007). This means 1 in 8 
fetuses are exposed to alcohol and placed at risk for FASDs. 
Maternal alcohol use is a growing worldwide phenomenon. 
It affects children and families of all ethnicities in all societies. 
Important international collaborative research is beginning 
to describe the alarming scope of this problem. While 
community and professional awareness of FASDs 
have increased, expanded awareness and informed action 
are sorely needed. 
FASDs cause a range of lasting medical and 
developmental problems and result in economic 
losses of billions of dollars. 
FASDs can also mean long-standing suffering for families.
FASDs are considered both medical conditions and 
developmental disabilities. They include a wide range of 
conditions, from subtle neurodevelopmental impairments 
to the full fetal alcohol syndrome (FAS). Individuals with 
FASDs can have physical, mental, behavioral, and/or learning 
disabilities with possible lifelong implications. Research shows 
that individuals with FASDs often have significant, long-
term deficits in functional life skills. These deficits lead to 
problems with day-to-day functioning as well as health care 
issues, including birth defects and increased risk for injury, 
unintended pregnancy, and sexually transmitted diseases. 
FASDs can also be associated with mental health difficulties, 
disrupted school and job experiences, trouble with the law, 
difficulties with independent living, substance abuse, problems 
with parenting, and more (Bertrand et al., 2004; Streissguth 
et al., 2004). The median adjusted annual cost of fetal alcohol 
syndrome has been estimated at $3.6 billion, but the costs 
associated with the entire fetal alcohol spectrum are surely 
much higher. 
Early, appropriate diagnosis of FASDs is a vital first 
step to improving outcomes for affected individuals 
and their families.
There is an emerging consensus on how to define FASDs; 
however, much research is needed to reach a diagnostic 
standard and to delineate the entire fetal alcohol spectrum. 
Diagnostic capacity is growing yet still insufficient in the 
United States, Canada, and abroad. For this reason, many 
individuals with FASDs are unrecognized or misdiagnosed. 
Efforts are ongoing to create and use standardized, reliable 
diagnostic systems across the globe and to continually 
improve guidelines as new knowledge emerges from research. 
Expert opinion from treating professionals, a wealth 
of family experience, compelling animal research, 
and pioneering intervention studies indicate 
that appropriate treatment of FASDs can have a 
measurable, positive impact. 
At the present time, even when appropriately diagnosed, 
individuals with FASDs often receive treatment that 
is incomplete or inappropriate. Without suitable 
treatment and interventions, individuals with FASDs 
may never reach their full potential. Not providing 
suitable treatment can also result in unnecessary costs as 
individuals enter systems (such as juvenile justice) with 
problems that data suggest could have been averted by 
earlier intervention. Families of affected individuals also 
need support within the medical and health care systems, 
and in early intervention and education, juvenile justice 
and corrections, substance abuse treatment, mental health 
systems, and social services. 
1
Fortunately, it is possible to define and address the treatment 
problems raised by FASDs. Because of increasing societal 
concern, especially over the past 10 years, important steps 
have been taken and the need for further action made very 
clear. In the United States, needs assessments have taken 
place through nationwide public town hall meetings and 
community agency initiatives (Ryan, Bonnett & Gass, 
2006). Intervention guidelines for FASDs are evolving in the 
United States, Canada, England, and other countries around 
the world. Strategic research plans are in place to stimulate 
better description of the entire fetal alcohol spectrum, hone 
diagnosis, and explain mechanisms of alcohol’s action on 
the developing child’s body and brain so that biomarkers 
and targeted treatments can be identified. An important but 
limited program of systematic FASD intervention research has 
begun in the United States and abroad. 
Collaboration between government agencies, 
professional organizations, researchers, and families 
is needed to adequately address FASDs.
In 2000, the United States Congress initiated a national 
forum for discussion of FASDs and interagency coordination 
at the federal level. Building on existing research, and advised 
by experts and parents, federal leaders have put in place 
strategic research plans for funding the study of FASDs. To 
promote further organized action, the Substance Abuse and 
Mental Health Services Administration’s (SAMHSA) FASD 
Center for Excellence has compiled a comprehensive database 
of available educational materials and products, research on 
FASDs, field-initiated efforts to educate professionals and 
the public, and community-based and/or research-driven 
efforts to provide services. Appendices B through F provide 
information on the efforts of the National Task Force on 
Fetal Alcohol Syndrome and Fetal Alcohol Effect, National 
Institute on Alcohol Abuse and Alcoholism (NIAAA), 
Centers for Disease Control and Prevention (CDC), 
SAMHSA through their FASD Center for Excellence, and the 
Interagency Coordinating Committee on FAS (ICCFAS). 
The groundwork has been laid to confront the 
serious public health problem presented by FASDs. 
It is reasonable, efficient, and humane to establish 
an integrated system of services for individuals 
and families affected by these conditions. This is 
a problem that can be dealt with, but momentum 
must be sustained. What is needed is well-informed 
public policy on FASDs and a clear, ongoing societal 
commitment to advancing research and ensuring 
essential services for persons with FASDs and 
their caregivers. 
 
RECOMMENDATIONS
The National Task Force on Fetal Alcohol Syndrome 
and Fetal Alcohol Effect has developed the following 
recommendations to respond to the need for essential 
services for and research on FASDs. Specific action 
steps to carry out these recommendations are found 
in Appendix A.
  1.  Modify eligibility and diagnostic classification systems 
to include FASDs so as to recognize FASDs as 
approved conditions under all federal disability-related 
benefit programs.
  2.  Improve diagnostic access by setting up screening 
systems for FASDs and increasing professional 
multidisciplinary diagnostic capacity in communities.
  3. Intensify research initiatives and interagency 
coordination to:
	 •	 delineate	the	full	fetal	alcohol	spectrum,
	 •	 continue	study	of	alcohol	mechanisms 
  and biomarkers,
	 •	 carry	out	longitudinal	descriptive	studies,
	 •	 establish	effective	interventions,
	 •	 translate	interventions	to	the	community,	and
	 •	 improve	the	quality	and	utilization	of	 
  interventions in all service systems for 
  those with FASDs. 
  4. Promote a comprehensive and accessible continuum 
of care for families raising infants, children, and 
adolescents with FASDs.
  5. Promote a comprehensive and accessible continuum 
 of care for youth, adults, and older individuals 
 with FASDs.
  6.  Encourage comprehensive professional education on 
FASDs, and assessment of knowledge gained, within 
multiple service systems. 
  7.  Enhance strong, collaborative, interagency 
 leadership at state and national levels (that includes 
parent representation) to inform legislators, 
policymakers, and the public.
  8. Recognize grassroots family support and advocacy 
organizations focused on FASDs, which are powerful 
and efficient agents of change.
  9. Improve ongoing national surveillance systems to 
identify individuals with FASDs to better track 
prevalence, provide needed intervention, and 
 assess the impact of prevention programs.
10. Maintain a national forum in which parents, 
advocates, professional organizations, and experts 
 in the field of FASDs can work to advance 
 essential services and research for individuals with 
FASDs and their families.
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FREQUENTLY ASKED QUESTIONS
What are FASDs?
FASDs are increasingly understood as a spectrum or 
continuum of effects found across many aspects of physical 
development, learning, and function (Warren et al., 2004). 
Individuals with FASDs can, but do not always, show 
adverse physical signs, such as characteristic facial anomalies 
or other body malformations. The learning and functional 
effects of prenatal alcohol exposure are the most troubling 
and difficult (but important) to identify, diagnose, and treat. 
These effects vary not only in type, but in severity. Some 
individuals can be mildly affected in one area of learning or 
behavior, but moderately or severely affected in another area. 
The range of FASDs includes the full fetal alcohol syndrome 
(FAS). Although FAS is found in a fairly small proportion 
of children affected by prenatal alcohol exposure, it is most 
easily diagnosed. Unfortunately, the effects of alcohol are 
not readily recognized if they do not fit the classic FAS 
definition. A larger number of children, adolescents, and 
adults have prenatal alcohol–induced impairments that can 
be just as serious, or more so, than those seen in people with 
FAS (Kodituwakku, 2007; Mattson, Riley, Gramling, Delis 
& Jones, 1998; Riley & McGee, 2005). The terms “partial 
FAS” and “alcohol-related neurodevelopmental disorder” 
(ARND) have been applied to these conditions, along with 
other diagnostic terms. In addition, some children prenatally-
exposed to alcohol are born without the characteristic facial 
features of FAS, but have other alcohol-related physical 
abnormalities of the skeleton and certain organ systems. 
These anomalies are referred to as “alcohol-related birth 
defects” (ARBD) (Alcohol Research & Health, 2000; 
Stratton, Howe & Battaglia, 1996).
How does alcohol affect fetal development?
Alcohol is a neurobehavioral teratogen—a substance that 
through prenatal exposure affects the body and (most 
importantly) the brain of a developing fetus. Alcohol 
alters how neurons and connections between neurons are 
formed. It also affects development at the cellular, hormonal, 
neurochemical, structural, and functional levels. It is thought 
that alcohol exposure affects fetal programming, laying 
the groundwork for atypical development and adverse life 
outcomes. Extensive animal research, long-term human 
descriptive studies, clinical studies, and neuroimaging research 
all come together to clearly show the lifelong negative impact 
that alcohol use during pregnancy can have on the developing 
child (Burden, Jacobson & Jacobson, 2005; Gemma, Vichi & 
Testai, 2007; Hannigan, O’Leary-Moore, & Berman, 2007; 
Kodituwakku, 2007; Miller & Spear, 2006; Sokol et al., 
2007; Spadoni, McKee, Fryer & Riley, 2007; Streissguth et 
al., 2004; Zhang, Sliwowska & Weinberg, 2005). 
How common are FASDs? 
In the United States, FASDs are now known to have a higher 
prevalence rate than previously thought and to occur across all 
ethnicities. The reported rates of FAS vary widely, depending 
on the population studied and surveillance methods used. 
CDC studies show FAS rates ranging from 0.2 to 1.5 cases 
per 1,000 live births. Such rates are comparable with or above 
other common developmental disabilities such as Down 
Syndrome or Spina Bifida (Bertrand et al., 2004). Other 
alcohol-related conditions resulting from prenatal exposure, 
such as partial FAS, ARND, and ARBD, are believed to occur 
about three times as often as FAS (Sampson et al., 1997). 
But the full extent of the problem is still under investigation, 
and improved prevalence studies are needed. Some have 
estimated the rates of the full range of FASDs as high as 9 or 
10 per 1,000 live births (May & Gossage, 2001; Sampson 
et al., 1997). Reasonable estimates translate to about 40,000 
alcohol-impacted births in the United States each year 
(Lupton, Burd & Harwood, 2004). FASDs are also a global 
health problem. FASDs are found worldwide, usually at rates 
similar to those in the United States. But some countries  
with even higher prevalence rates have reached out for 
guidance and collaboration in research efforts to address 
FASDs. Many nations have had long-standing concern about 
FASDs, and there is now emerging alarm in countries that 
had not previously recognized the problem. (Viljoen et al., 
2005; May et al., 2006).
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What are the costs of FASDs? The costs of FASDs are both 
human and financial. The human costs of FASDs arise from 
the debilitating secondary disabilities found among affected 
individuals, and the emotional and financial burdens on 
their families—made clear in nationwide town hall meetings 
that took place from 2002 to 2005 (Ryan, Bonnett & Gass, 
2006). For instance, parents raising children with clearly 
diagnosed FASDs report clinically elevated levels of stress 
(Paley, O’Connor, Frankel & Marquardt, 2006). Careful 
estimates of economic cost data in the United States for the 
full fetal alcohol syndrome (FAS) reveal that it is one of the 
most costly birth defects. Lupton and colleagues (2004) 
estimated that the median adjusted annual cost of FAS to 
the U.S. economy is $3.6 billion. They also estimated that 
the adjusted total lifetime cost per individual with FAS (as of 
2002 and updated based on the medical services price index) 
was $2.9 million. Annual state cost estimates vary depending 
on population and female at-risk drinking rates. More details 
on published cost studies can be found on SAMHSA’s FASD 
Center for Excellence website (www.fasdcenter.samhsa.gov). 
Little is known about costs of the wider fetal alcohol spectrum 
beyond FAS, but additional affected individuals can only 
further raise societal costs and caregiving burden. 
Where Are We Now in Responding to FASDs? 
Prevention of FASDs and community education 
remain important. 
Pregnant women are advised to abstain from all alcohol 
use, a long-standing federal advisory that is also supported 
by major professional societies (e.g., American College of 
Obstetricians & Gynecologists, 2005). However, studies 
conducted by the CDC (2004) and SAMHSA (2007) found 
that 12% of pregnant women reported consuming alcohol, 
with 2-3% reporting binge drinking (5 or more drinks per 
drinking occasion). Of the approximately 4 million live 
births in the United States per year, this translates to almost 
a half million women consuming alcohol during pregnancy 
with an estimated 80,000-120,000 women drinking alcohol 
at levels that place their babies at increased risk for adverse 
outcomes. In another study, approximately 3% of pregnant 
women reported drinking at levels that have been consistently 
associated with adverse effects on the fetus (Jacobson & 
Jacobson, 1999). Also, more than half of all women of 
childbearing age (18 through 44 years of age) reported 
alcohol use, and approximately one in eight reported binge 
drinking in the past month (CDC, 2004; SAMHSA, 2007). 
Given that half of U.S. pregnancies are unplanned (Finer 
& Henshaw, 2006), this rate of drinking among women of 
childbearing age poses a substantial risk for FASDs.
In response to this public health concern, a clinical plan of 
action for reducing adverse outcomes from prenatal alcohol 
exposure has been proposed (Floyd, O’Connor, Bertrand & 
Sokol, 2006). Some progress has been made in preventing 
FASDs, although prevention must remain a major aim. 
Educational approaches on screening for and preventing 
women’s drinking have been developed. Both brief and 
indicated, longer-term preventive treatment methods have 
been tested. The National Task Force on Fetal Alcohol 
Syndrome and Fetal Alcohol Affect recently reviewed the 
evidence to date on effective prevention methods to reduce 
alcohol use and alcohol-exposed pregnancies— and developed 
recommendations to inform future research, practice, and 
public policy regarding prevention of FASDs (Barry et al., 
4
52009).  Community awareness of FASDs has increased, but 
must expand. A broad range of educational materials have 
been created, and these materials need wider dissemination. 
Importantly, pivotal federal task forces and professional 
societies are beginning to take a stand on prevention of 
FASDs and producing guidelines for how to respond (e.g., 
American Academy of Pediatrics, 2000; American College of 
Obstetricians & Gynecologists, 2006; NIAAA, 2005; U.S. 
Preventive Services Task Force, 2004). 
Prevention of FASDs can be achieved. Evidence is accumulating 
that preventive intervention can reduce prenatal alcohol use 
and increase family planning efforts (e.g., Chang, McNamara 
& Orav, 2005; Floyd et al., 2007; Grant, Ernst, Streissguth & 
Stark, 2005; O’Connor & Whaley, 2007). It is important to 
assess different preventive approaches (universal, selective, and 
indicated) targeting different types of populations (Hankin, 
2002), and to study the success of multi-level, community-wide 
prevention efforts. Continuing, definitive prevention research, 
including innovations such as the study of neuroprotective 
agents, is crucial. But prevention of FASDs cannot be the only 
response to this set of developmental disabilities. 
Accurate detection and expanded diagnosis of  FASDs 
are essential. Even with prevention efforts, many children 
are born with FASDs and need diagnosis and appropriate 
intervention across the lifespan. Their families, schools, service 
systems, and larger communities need support and effective, 
practical ways to respond. Surveillance programs and research 
are underway to understand women’s drinking and rates of 
FAS. There are small but lively research programs studying 
biomarkers and alcohol exposure ascertainment. This research 
will allow better screening and detection in pregnancy or early 
infancy. Researchers are actively studying the reliability of 
existing FASD diagnostic systems, while also collaborating to 
improve diagnostic methodology through technology such as 
imaging and both 2-D and 3-D facial modeling. Research to 
case-define disorders along the entire fetal alcohol spectrum 
is underway, using behavioral and physical methodologies, 
including brain imaging. Better case definitions will allow 
more precise estimates of prevalence across the full range of 
FASDs. In particular, there is a crucial need to case-define 
alcohol-related neurodevelopmental disorder (ARND), which 
has not yet been adequately described, although research is 
actively being pursued. These promising research programs 
must continue in order to expand and build momentum to 
accomplish the goals of precision in estimating prevalence 
and incidence; in detecting prenatal alcohol exposure and 
the possible presence of FASDs as early as possible; and 
in developing clear diagnoses. Meanwhile, though, useful 
diagnostic guidelines do exist (e.g., Bertrand et al., 2004; 
Chudley et al., 2005). Practical and increasingly widely 
used diagnostic systems that can describe the full range of 
alcohol-related disabilities are in use, and successful models 
for diagnostic clinics do exist. What is urgently needed is a 
significant increase in FASD diagnostic capacity  
and accessibility.
Intervention for individuals with FASDs is a high 
priority. There is real hope that with appropriate and early 
intervention, children with FASDs can have improved 
outcomes. Basic animal research and human studies are 
building the case that diagnosis and intervention can change 
outcome. Research on animal models of FAS suggests 
that there is neuronal plasticity and that appropriate 
environmental enrichment and motor training has potential 
to improve behavioral and learning outcomes and reduce 
alcohol-induced injury to the brain and central nervous 
system. This is thought to be especially true early in life, but 
even to occur during the animal equivalent of adolescence or 
early adulthood (e.g., Hannigan et al., 2007). Animal research 
suggests that pharmacological treatments may also have 
positive effects (e.g., Vaglenova et al., 2007). Natural history 
research on clinical human samples highlights “protective 
factors” that are related to reduced odds that negative 
outcomes in functional life skills will occur among individuals 
with FASDs (Streissguth et al., 2004). These protective factors 
can be enhanced through intervention. 
Infant mental health studies and early intervention research 
among children with a variety of developmental disabilities 
suggest strong potential for positive change if intervention 
is designed on the basis of current scientific data about child 
development and early psychopathology (Olson, Jirikowic, 
Kartin & Astley, 2007). Treatment in the school years 
or adolescence can likely improve educational outcomes 
and functional life skills, and prevent or reduce secondary 
disabilities and debilitating family strife (Coles, Strickland, 
Padgett & Bellmoff, 2006; Kalberg & Buckley, 2007). 
Indeed, recent carefully controlled FASD intervention 
studies in the United States show positive effects for school-
age children and families (Coles et al., 2009; Interventions 
for Children with FASDs Research Consortium, in press; 
Kable et al., 2007; O’Connor et al., 2006; Olson et al., 
2005), and pilot studies in the United States and abroad 
show promise (e.g., Adnams et al., 2007). Even as late as 
adulthood, diagnosis and intervention for individuals with 
FASDs are deemed crucial (especially holistic treatment and 
management of associated mental disorders), and can likely 
reduce suffering and cost to affected individuals and those 
who care for them (Streissguth & O’Malley, 2000). Many 
promising intervention ideas exist, and parents and providers 
are discussing what is needed within the full continuum of 
services (Olson, 2006). Some field-initiated intervention 
projects are also underway in the United States (see 
SAMHSA’s FASD Center for Excellence  
[www.fasdcenter.samhsa.gov] and CDC websites  
[www.cdc.gov/ncbddd/fas]), and several international 
cooperative projects for prevention and intervention with 
FASDs are operating, as part of global outreach to resource-
poor countries (Calhoun et al., 2006). But these services and 
beginning intervention research are truly only a foundation. 
Much work remains to be done in the high-priority, under-
funded, and relatively unexplored area of intervention for 
FASDs. Intervention research should become a major focus 
in the field of FASDs. Research should be programmatic 
and, when possible, conducted in randomized control trials, 
and held to standards that will generate an appropriate 
evidence base.
Ongoing communication and cooperation between 
government, professional organizations, researchers, 
and families are imperative.
The basic systems needed to ensure advancement in the field 
of FASDs do exist, and it is imperative that these systems 
be maintained. Since the mid 1970s, student and senior 
basic scientists, animal researchers, and clinical investigators 
interested in FASDs have met together as the FASD Study 
Group (see http://rsoa.org/fas.html). This research inter-
change, which began spontaneously, now includes efficient 
interaction with agencies interested in FASDs, has been 
encouraged by the NIAAA, and has resulted in faster research 
progress. There is currently a productive and wide-ranging 
research environment exploring FASDs, although the num-
ber of researchers remains relatively small (Bonthius, Olson 
& Thomas, 2006). The NIAAA and CDC have agendas 
for research on FASDs (see Appendices C and D). Family 
advocacy groups have increasingly coalesced across the United 
States and abroad, including the National Organization on 
Fetal Alcohol Syndrome (NOFAS), which recently gathered 
an FASD Congressional Caucus (see www.nofas.org). In the 
last 10 years, increasing cooperation on many other levels has 
boosted progress on the public health problem of FASDs. In 
2000, Congress mandated creation of the National Task Force 
on Fetal Alcohol Syndrome and Fetal Alcohol Effect with par-
ticipation from governmental agencies and research funding 
bodies, professional organizations, family advocacy groups, 
and experts in the field of FASDs, with Task Force activities 
open to public comment (sunset for the Task Force occurred 
in 2007; see Appendix B). In 2001, SAMHSA’s FASD Center 
for Excellence was created with multiple initiatives, and with 
impetus from the public, has fortunately been refunded 
by SAMHSA (see Appendix E). In 1996, the Interagency 
Coordinating Committee on FAS (ICCFAS) was created, 
with participation by decision-makers in the many service 
systems affected by FASDs (see Appendix F). Experience has 
shown that communication and cooperation in this field can 
function well, inspire creativity, enhance efficiency, and drive 
progress. Collaboration and integration in research, practice, 
and public policy must continue.
What are the Next Steps?
Now is the time to build on earlier momentum and renew 
efforts to meet the challenge of FASDs. This is a call to action. 
Without continued momentum, public will could falter, 
and the coordinated agency efforts, innovative research, and 
family-professional partnerships that have been created in the 
past decade could break down. Dismantling these efforts and 
starting over is highly inefficient and impractical. Instead, 
the most efficient, logical, and hopeful course is to maintain 
and strengthen what has already been set in place, is working 
well, and simply needs to be expanded and made sustainable. 
It is not only possible, but ethically imperative, that efforts 
continue to significantly improve outcomes for individuals 
with FASDs. These efforts can reduce the drain on emotional, 
physical, and financial resources that have devastated too 
many families and strained service delivery systems. 
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  3. Intensify research initiatives and interagency 
 coordination to: 
	 •	 Delineate	the	full	fetal	alcohol	spectrum,	including	
fetal alcohol syndrome (FAS), partial FAS, and alcohol-
related neurodevelopmental disorder (ARND).
	 •	 Work	toward	consensus	on	objective	diagnostic	criteria	
for the full fetal alcohol spectrum.
	 •	 Continue	study	of	alcohol	mechanisms	and	the	impact	
of intervention using animal models.
	 •	 Improve	understanding	of	the	mechanisms	of	alcohol’s	
action on the brain through neuroimaging and basic 
science studies.
	 •	 Enhance	prevention	and	early	detection	through	
research to identify maternal and fetal biomarkers.
	 •	 Improve	understanding	of	neuroprotective	factors.
	 •	 Study	the	long-term,	natural	developmental	course	of	
individuals with FASDs.
	 •	 Identify	and	test	useful	instructional	methods	for	
individuals with FASDs.
	 •	 Create	and	establish	the	efficacy	of	intervention	
approaches for individuals with FASDs and their 
caregivers (including behavioral, psychopharmacology, 
and combined treatments).
	 •	 Translate	effective	identification,	diagnosis,	and	
intervention strategies to community settings.
	 •	 Improve	the	quality	and	utilization	of	interventions	in	
all services systems for those with FASDs.
  4. Promote a comprehensive and accessible continuum 
of care for families raising infants, children and 
adolescents with FASDs. 
	 •	 Require	updated	education	and	training	for	healthcare,	
mental health providers, early interventionists, 
and educators on: FASDs; the family perspective; 
identification, referral and effective intervention; and 
how to emphasize functional life skills.
	 •	 Promote	caregiver	stress	reduction	through	increased	
access to flexible respite care services. 
	 •	 Establish	a	continuum	of	scientifically	tested	or	
promising interventions, specialized for FASDs, that 
can address the full range of severity of family needs 
and child/adolescent problems:
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1Critical systems with points of entry and exit that need to set up effective strategies for screening, 
referral and treatment planning: newborn screening, early periodic screening, diagnosis and 
treatment (EPSDT), early intervention, child welfare and foster care, special education, family 
court proceedings, juvenile and criminal justice, WIC programs, inpatient psychiatric care, and 
chemical dependency treatment.
 APPENDIX  A
Action Steps for Recommendations of the National Task Force 
on Fetal Alcohol Syndrome and Fetal Alcohol Effect
  1.  Modify eligibility and diagnostic classification systems 
 to include FASDs, so as to recognize FASDs as 
approved conditions under all federal disability-
related benefit programs. 
	 •	 Modify	Medicaid	and	insurance	coding	policies	to	
appropriately fund screening, diagnosis, treatment, and 
support services for individuals with FASDs.
	 •	 Make	the	following	changes	to	the	Child	Abuse	&	
Prevention Act (CAPTA) provision: 
  — Add “and prenatal alcohol exposure” to the current 
CAPTA provision that requires referral to early 
intervention by social services and healthcare 
   providers of children born drug-exposed. 
  — Expand the age of referral to Child Find and early 
intervention services for children to “up to age 
five” in the current CAPTA provision.
	 •	 Amend	the	recently	reauthorized	Individuals	with	
Disabilities Education Act (IDEA) of 2004:
  — Include individuals with FASDs for eligibility 
under Part C and Part B. 
  — Include technical assistance related to identifying 
children and youth with FASDs in Part D.
	 •	 Work	toward	consensus	on	objective	diagnostic	criteria	
for the full fetal alcohol spectrum.
	 •	 Directly	and	fully	respond	to	FASDs	in	the	classification	
systems of the widely-used psychiatric Diagnostic and 
Statistical Manual of Mental Disorders (American 
Psychiatric Association, 1994; now under revision), and 
the medical International Code for Diseases (ICD-10) 
(World Health Organization, 2005). 
  2. Improve diagnostic access by setting up screening 
systems for FASDs and increasing professional 
multidisciplinary diagnostic capacity in communities.
	 •	 Require	that	critical	systems	with	points	of	entry	and	
exit set up effective strategies for screening, referral and 
treatment planning.1  
	 •	 Ensure	local	access	to	screening	by	requiring	training	
on awareness of FASDs for providers in systems where 
screening takes place.
	 •	 Promote	regional	access	to	appropriate	multidisciplinary	
diagnostic and treatment services that reduce drive-time 
and waiting lists for families, including (when feasible 
and efficient) specialized FASD diagnostic clinics.
	 •	 Ensure	that	efforts	toward	FASD	prevention,	substance	
use education, and referral for chemical dependency 
treatment are included in FASD diagnostic services.
  — For example: Parent-to-parent support, parenting 
groups, child groups, social skills training, teen 
groups and retreats, summer camps, ongoing 
individualized behavioral and/or learning readiness 
consultation services for families with children 
at high risk, parent-child assistance programs for 
women with chemical dependency problems, 
direct child treatments (e.g., computer training, 
self-regulation techniques), special instructional 
programming and school behavior plans.
5. Promote a comprehensive and accessible continuum 
of care for youth, adults and older individuals 
 with FASDs.
	 •	 Modify	eligibility	for	existing	vocational	and	supported	
living/housing services to include individuals with 
FASDs (which may include altering current IQ and 
functional level requirements).
	 •	 Promote	creation	of	strength-based	programs	that	
include protective oversight as well as gradual, 
supported progressive skill-building (e.g., mentoring 
programs, supported living).
	 •	 Develop	and	use	appropriate	alternative	strategies	
within juvenile justice systems and corrections 
programs to ensure safety and effective diversion or 
rehabilitation of individuals with FASDs.
	 •	 Recognize	that	FASDs	can	be	a	“transgenerational”	
problem—with affected individuals becoming involved 
in substance use and sexual activity, and so at risk 
for (or having) affected children. Because of this, 
promote specialized, intensive FASD prevention, 
chemical dependency treatment, and parenting support 
programs for youth and adults with FASDs.
6. Encourage comprehensive professional education on
 FASDs, and assessment of knowledge gained, within
 multiple service systems.2 
	 •	 Provide	technical	assistance	on	FASDs	through	
specialized regional training centers and federal 
technical assistance systems.
	 •	 Include	information	on	FASDs	in	pre-service	
  training, board examinations, licensing mechanisms, 
  and continuing education for providers in 
  multiple service systems.
7. Enhance strong, collaborative, interagency leadership 
at state and national levels (that includes parent 
representation) to inform legislators, policymakers, 
 and the public.
	 •	 Maintain	high-level	interagency	coordination	activities,	
such as those of the Interagency Coordinating 
Committee for FAS (ICCFAS).
	 •	 Promote	coordinated	state	systems	to	respond	to	
FASDs, including appointing state-level FASD 
coordinators following the lead of SAMHSA initiatives.
	 •	 Establish	or	maintain	a	lead	federal	agency	to	promote	
field-initiated and translational research and facilitate 
comprehensive systems of care over the lifespan.
 8. Recognize grassroots family support and advocacy
 organizations focused on FASDs, which are powerful 
 and efficient agents of change.
	 •	 Use	existing	FASD	organizations	to	educate	and	
monitor policy. Possible actions: host U.S. House 
and Senate briefings; sponsor FASD Education Days; 
conduct personal meetings with legislators.
	 •	 Disseminate	state-of-the-art	research	and	policy	
changes through existing databases and websites.
	 •	 Maintain	the	FASD	Caucus	in	the	U.S.	Senate,	
promoting and monitoring membership.
	 •	 Maintain	the	organized	birth	mother/family	movement	
to promote FASD prevention and support for recovery 
from addiction.
	 •	 Maintain	an	organized	effort	to	continue	
communication to family groups and coalitions 
  about gains from FASD prevention, diagnosis and 
treatment, and remaining prevention, diagnostic, 
  and treatment needs.
9. Improve ongoing national surveillance systems to
 identify individuals with FASDs to better track 
prevalence, provide needed intervention, and assess 
the impact of prevention programs.
	 •	 Increase	the	number	of	states	carrying	out	surveillance	
of FAS and partial FAS, especially: effective, active 
surveillance, and incorporating FAS/PFAS into existing 
birth defects surveillance systems.
	 •	 When	identification	methods	become	available,	
increase the number of states carrying out 
effective, active surveillance of alcohol-related 
neurodevelopmental disorder (ARND).
10.  Maintain a national forum in which parents, 
advocates, professional organizations, and experts 
in the field of FASDs can work to advance essential 
services and research for individuals with FASDs 
and their families.
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2Target service systems in need of comprehensive professional education on FASDs, and assessment 
of knowledge gained: health care (obstetrics/gynecology, pediatrics, internal medicine, family 
practice, nursing), allied professions (occupational therapy, speech-language pathology), mental 
health (e.g., psychiatry, psychology, social work, counseling), early intervention, regular and 
special education, child welfare, developmental disabilities, vocational services, juvenile justice and 
corrections, and chemical dependency treatment.
SELECTED ACCOMPLISHMENTS
•	 The	Task	Force	outlined	a	national	agenda	for	FAS	and	
other prenatal alcohol-related conditions in a 2002 
MMWR Recommendations and Reports publication, 
National Task Force on Fetal Alcohol Syndrome and Fetal 
Alcohol Effect: Defining a National Agenda for Fetal 
Alcohol Syndrome and Other Prenatal Alcohol Related 
Disorders (MMWR, 2002).
•	 Several	Task	Force	members	participated	on	the	Scientific	
Working Group (SWG) on Diagnostic Guidelines for 
FAS and ARND Meeting in July 2002, provided input 
in various SWG committees, and deliberated on and 
approved Fetal Alcohol Syndrome: Guidelines on Referral 
and Diagnosis (Bertrand, et al., 2004). 
•	 Recommendations	were	sent	to	the	Office	of	Education	
to include FAS in the reauthorization of the Individuals 
with Disabilities in Education Act (IDEA) of 2004. 
•	 In	2004,	the	Task	Force	endorsed	the	consensus	
definition of the term “fetal alcohol spectrum disorders” 
(FASDs) developed through an expert panel convened by 
the National Organization on Fetal Alcohol Syndrome. 
•	 In	2005,	the	Task	Force	supported	efforts	to	bring	
FASDs to the attention of the American Psychiatric 
Association in its deliberations on the 5th Edition of the 
Diagnostic and Statistical Manual of Mental Disorders. 
•	 Task	Force	recommended	an	updated	release	of	the	
Surgeon General’s advisory on alcohol and pregnancy 
in 2001. This request was reviewed and approved by the 
Task Force and received key federal agency support. The 
Surgeon General’s Advisory on Alcohol Use in Pregnancy 
was released in 2005 (Office of the Surgeon General, 
2005). Task Force and liaison members, along with 
various federal agencies, were also involved in activities 
 to disseminate the Advisory. 
•	 A Call to Action: Advancing Essential Services and Research 
on Fetal Alcohol Spectrum Disorders was developed and 
approved by the Task Force in 2007. This document 
emphasizes the importance of early identification, 
diagnostic services, and quality research on interventions 
for individuals with FASDs and their families. 
Recommendations on continuing and enhancing these 
kinds of activities are outlined.
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 APPENDIX B
Accomplishments of the National Task Force on Fetal Alcohol Syndrome 
and Fetal Alcohol Effect
BACKGROUND
In 1998, the U.S. Congress recognized the significance of a 
coordinated effort to address the concerns related to FAS and 
fetal alcohol effects (FAE). The Secretary of the U.S. Department 
of Health and Human Services (DHHS) was directed through 
the Public Health Service Act, Section 399G (42 U.S.C. Section 
280f, as added by Public Law 105-392) to establish a National 
Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect 
(the Task Force) that would: (1) foster coordination among all 
governmental agencies, academic bodies, and community groups 
that conduct or support FAS and FAE research, programs, and 
surveillance; and (2) otherwise meet the needs of populations 
impacted by FAS and FAE. On May 17, 2000, in accordance 
with Public Law 92-463, the Task Force was chartered. Authority 
to establish the Task Force was delegated to CDC’s National 
Center on Birth Defects and Developmental Disabilities 
(NCBDDD). NCBDDD’s Fetal Alcohol Syndrome Prevention 
Team was assigned primary responsibility for establishing the Task 
Force and managing its operations. The Task Force function, as 
outlined in its charter (DHHS, 2000), is to:
•	 Advise	persons	involved	in	federal,	state,	and	local	programs	
and research activities of FAS and FAE regarding such topics as 
FAS awareness and education for relevant service providers and 
the general public (including school-aged children and women 
at risk), medical diagnosis for FAS and FAE, prevention and 
intervention strategies for women at risk, and essential services 
for affected persons and their families; 
•	 Coordinate	its	efforts	with	the	DHHS	Interagency	
Coordinating Committee on Fetal Alcohol Syndrome 
(ICCFAS); and 
•	 Report,	on	a	biennial	basis,	to	the	DHHS	Secretary	and	
relevant committees of Congress on the current and planned 
activities of the participating agencies.
•	 Reducing Alcohol-Exposed Pregnancies: A Report of 
 the National Task Force on Fetal Alcohol Syndrome 
 and Fetal Alcohol Effect was developed and approved 
by the Task Force in 2007. This report reviews 
current evidence on prevention strategies to reduce 
alcohol use and alcohol-exposed pregnancies, provides 
recommendations on promoting and improving these 
strategies, and offers future research directions in the 
 field of FASD prevention.
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For more information, see National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol 
Effect web site.  http://www.cdc.gov/ncbddd/fas/taskforce.htm
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 APPENDIX C
Overview of the Strategic Research Plan on FASDs from
the National Institute on Alcohol Abuse and Alcoholism
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Since the initial U.S. discovery of the detrimental effects of 
prenatal alcohol exposure, a substantial portion of the NIAAA 
research budget has been dedicated each year to research on 
FASD-related issues. The NIAAA research portfolio includes 
projects whose goals are prevention of drinking during 
pregnancy, increased understanding of the etiology of alcohol-
attributable fetal injury, better diagnosis of FASD, and 
development of interventions to reduce the effects of prenatal 
alcohol exposure, mitigate the consequences of alcohol-
induced injury, and improve the quality of life for persons 
with FASD. Furthermore, the NIAAA research portfolio 
on prevention of alcohol use disorders supports prevention 
research studies specifically aimed at reduction of drinking 
by both non-pregnant and pregnant women of childbearing 
age. The NIAAA supports the activities of the Interagency 
Coordinating Committee on Fetal Alcohol Syndrome 
(ICCFAS) and collaborates with many other federal agencies 
whose missions and/or program interests include FASD. In 
addition to conducting and supporting FASD-related research 
the NIAAA also regularly produces publications summarizing 
research results, clinical guidelines, and educational materials 
relevant to FASD. Check the NIAAA Web site for the most 
recent version of the NIAAA Strategic Plan, more details 
about the FASD research program, and currently available 
publications: http://www.niaaa.nih.gov/
For more information, see: 
National Institute on Alcohol Abuse and Alcoholism 
(NIAAA). (2006, July). 
NIAAA: Five-year strategic plan (FY 07-11): Alcohol 
across the lifespan. http://pubs.niaaa.nih.gov/publications/
StrategicPlan/NIAAASTRATEGICPLAN.htm
See also the link to research aims specifically for study 
of  FAS and prenatal alcohol exposure, as it applies 
to health disparities: 
http://www.niaaa.nih.gov/AboutNIAAA/
OrganizationalInformation/HealthDisparities2005.htm
OVERVIEW
The National Institute on Alcohol Abuse and Alcoholism 
(NIAAA) is one of the 27 Institutes and Centers which 
comprise the National Institutes of Health, “The Nation’s 
Medical Research Agency,” a component of the U. S. 
Department of Health and Human Services. The NIAAA 
is the primary U.S. agency for conducting and supporting 
research on the causes, consequences, prevention, and 
treatment of alcohol abuse, alcoholism, and alcohol 
problems— and the NIAAA disseminates research findings 
to general, professional, and academic audiences. 
The NIAAA mission is to provide leadership in the national 
effort to reduce alcohol-related problems by: 
•	 Conducting	and	supporting	research	in	a	wide	range	
of scientific areas including genetics, neuroscience, 
epidemiology, health risks and benefits of alcohol 
consumption, prevention, and treatment 
•	 Coordinating	and	collaborating	with	other	research	
institutes and Federal Programs on alcohol-related issues 
•	 Collaborating	with	international,	national,	state,	and	
local institutions, organizations, agencies, and programs 
engaged in alcohol-related work 
•	 Translating	and	disseminating	research	findings	to	health	
care providers, researchers, policymakers, and the public
The NIAAA’s efforts to fulfill its mission are guided by the 
Director’s Vision to support and promote the best science 
on alcohol and health for the benefit of all by:
•	 Increasing	the	understanding	of	normal	and	abnormal	
biological functions and behavior relating to alcohol use 
•	 Improving	the	diagnosis,	prevention,	and	treatment	of	
alcohol use disorders 
•	 Enhancing	quality	health	care
APPENDIX D
Activities of the Centers for Disease Control and Prevention 
Related to Fetal Alcohol Spectrum Disorders
Current activities include:
•	 Prevention	efforts
  — Implementing state-based FASD prevention projects
  — Conducting intervention research for preventing
   alcohol-exposed pregnancies
  — Identifying alcohol-exposed pregnancies through
   biomarkers
•	 Monitoring	efforts	
 — Tracking alcohol use among childbearing-
  aged women
 — Establishing and guiding the implementation of 
surveillance systems for the prevalence of FAS 
through state-based projects
 — Assessing health care providers’ knowledge, attitudes, 
and practices regarding screening for alcohol 
use, provision of brief interventions, and care of 
individuals with FASDs
•	 Interventions	for	children	with	FASDs
 — Implementing tested intervention strategies for 
children living with FASDs in community-based 
settings
•	 Education	efforts
 — Supporting FASD Regional Training Centers for 
medical and allied health students and practitioners
 — Developing screening and intervention tools for 
women’s health care providers
 — Responding to public inquiries and disseminate 
educational materials to various audiences
•	 International	efforts	in	South	Africa,	Denmark,	and	Russia
•	 Partner	engagement
 — Coordinating the National Task Force on Fetal 
Alcohol Syndrome and Fetal Alcohol Effect
 — Promoting various collaborations with internal and 
external partners
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Fetal Alcohol Syndrome Prevention Team
Prevention Research Branch
Division of Birth Defects and Developmental Disabilities
National Center on Birth Defects and
Developmental Disabilities
MISSION
The mission of the Centers for Disease Control and 
Prevention’s (CDC) Fetal Alcohol Syndrome (FAS) 
Prevention Team is to prevent FAS and other prenatal 
alcohol-related conditions and ameliorate these conditions 
in children already affected. 
BACKGROUND/OVERVIEW
CDC has been involved in FAS-related activities since 1991. 
The FAS Prevention Team resides in the National Center 
on Birth Defects and Developmental Disabilities, Division 
of Birth Defects and Developmental Disabilities, at CDC. 
Recently, the FAS Prevention Team became part of the 
Prevention Research Branch, one of three branches within 
the division. The FAS Prevention Team currently funds a 
total of 26 cooperative agreements in 18 states, as well as 3 
international projects. Some of these cooperative agreements 
also reach out to additional states. 
FAS PREVENTION TEAM EFFORTS
The FAS Prevention Team works to develop systems to 
monitor exposures and outcomes; to conduct epidemiologic 
studies and public health research to identify maternal risk 
factors associated with giving birth to a child with FAS or 
another prenatal alcohol-related condition, known collectively 
as fetal alcohol spectrum disorders (FASDs); and to implement 
and evaluate prevention and intervention programs.
Recent Accomplishments
•	 Developing	Fetal Alcohol Syndrome: Guidelines for Referral 
and Diagnosis in 2004.
•	 Participation	in	implementing	the	2005	U.S.	Surgeon	
General’s Advisory on Alcohol Use in Pregnancy, in 
collaboration with the National Task Force on Fetal 
Alcohol Syndrome and Fetal Alcohol Effect, relevant 
federal agencies, and other partners.
•	 Developing	and	disseminating	of	a	tool	kit	for	women’s	
health care providers, in partnership with the American 
College of Obstetricians and Gynecologists, in 2006. 
This tool kit helps providers screen female patients for 
risky drinking and deliver brief interventions for those at 
risk for an alcohol-exposed pregnancy.
•	 Completing	Project	CHOICES	(2007),	which	found	
that women who received brief motivational counseling 
sessions were twice as likely to reduce their risk for 
an alcohol-exposed pregnancy as women who did 
not receive the counseling. Risk was reduced either 
by decreasing alcohol use, by using more effective 
contraception, or both. 
•	 Developing	systematic,	specific,	and	scientifically	
evaluated interventions for children with FASDs 
currently underway.
Future Directions
•	 Exploring	the	feasibility	of	establishing	ongoing	FAS	
surveillance as part of the National Birth Defects 
Prevention Network and the Metropolitan Atlanta 
Congenital Defects Program.
•	 Promoting	continued	dialogue	with	the	FASD	field	
regarding diagnostic criteria for prenatal alcohol-related 
conditions other than FAS.
•	 Continuing	to	monitor	alcohol	consumption	rates	
among women of childbearing age.
•	 Conducting	epidemiological	studies	to	identify	other	risk	
factors commonly found in combination with the risk for 
an alcohol-exposed pregnancy.
•	 Exploring	the	effect	of	multiple-risk	factor	interventions	
on reducing alcohol-exposed pregnancies.
•	 Conducting	further	testing	of	the	Project	Choices	
intervention model targeting women in diverse, 
population-based settings not previously studied (e.g., 
American Indian/Alaska Native populations, worksite 
programs, health insurance agencies)
•	 Packaging	and	disseminating	the	Project	CHOICES	
intervention for various public health and social 
 service audiences.
•	 Expanding	the	translation	of	CDC’s	model	programs	for	
intervening with children with FASDs and their families.
•	 Continuing	to	support	provider	education	regarding	the	
recognition of FASDs and the identification of women at 
risk for an alcohol-exposed pregnancy.
•	 Continuing	to	inform	consumers,	health	providers,	and	
other groups about FASDs and the risks of drinking 
alcohol during pregnancy.
To learn more about FASDs and CDC’s FASD program 
activities, visit http://www.cdc.gov/ncbddd/fas/ or http://
www.cdc.gov/ncbddd/fas/cdcactivities.htm.
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APPENDIX E
Overview of the Substance Abuse and Mental Health Services 
Administration’s FASD Center for Excellence
MISSION STATEMENT
The mission of the FASD Center for Excellence is to facilitate 
the development and improvement of prevention, treatment, 
and care systems in the United States by providing national 
leadership and facilitating collaboration in the field.
Vision of the FASD Center
1. Reduce the number of infants born prenatally 
 exposed to alcohol.
2. Increase functioning of persons who have an FASD.
3. Improve quality of life for individuals and families 
affected by FASD.
Goals of the FASD Center 
1. Facilitate the development of FASD prevention, 
treatment, and care as a specialty field.
2. Facilitate the development of FASD prevention, 
treatment, and care systems at the State and 
 community level. 
For more information, see: http://www.fasdcenter.samhsa.gov/
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The Substance Abuse and Mental Health Services 
Administration (SAMHSA), United States Department 
of Health and Human Services (HHS), is the lead Federal 
agency addressing substance abuse and mental health services. 
SAMHSA’s mission is to build resilience and facilitate 
recovery for people with or at risk for substance abuse and 
mental illness. SAMHSA was established as a services agency 
in 1992, though its predecessors have existed within the 
Public Health Service since 1930.
The SAMHSA FASD Center for Excellence was launched 
in 2001. Congress authorized the Center in Section 519D 
of the Children’s Health Act of 2000, which included six 
mandates (Section b of 42 USC 290bb-25d or Public Law 
106-310). The mandates focus on exploring innovative service 
delivery strategies, developing comprehensive systems of care 
for FASD prevention and treatment, training service system 
staff, families, and individuals with an FASD, and preventing 
alcohol use among women of childbearing age.
APPENDIX F
Information about the Interagency Coordinating Committee 
on Fetal Alcohol Syndrome
The ICCFAS increases communication among participating 
organizations via shared meetings, workshops, planning 
sessions, and formal information exchanging sessions. 
Collaboration has been increased by co-sponsorship of 
conferences, research programs, observational studies, and 
outreach activities. Cooperation has been increased by 
representatives from ICCFAS member agencies providing 
service to each other as speakers at conferences, meetings, and 
workshops and in writing articles for newsletters sponsored 
by other participating organizations. Furthermore, ICCFAS 
members provide assistance as advisors and consultants 
to fellow members and their agencies. These advisory and 
consultant roles have been in the form of service on formal 
advisory committees, help with preparation of program 
announcements and requests for applications, review of 
proposals, and assistance in launching outreach programs.
The membership of the ICCAFS is dynamic, changing 
as federal agencies emphasize different aspects of their 
missions. The FY2007 membership of the ICCFAS included 
representatives from the following organizations:
______________________________________________
•	 Department	of	Justice	(DOJ),	Office	of	Juvenile	Justice	
and Delinquency Prevention (OJJDP)
•	 Department	of	Education	(ED),	Office	of	Special	
Education and Rehabilitative Services (OSERS)
•	 Department	of	Health	and	Human	Services	(DHHS)
 — Agency for Heathcare Research and Quality (AHRQ) 
 — Centers for Disease Control and Prevention (CDC) 
 — Health Resources and Services Administration (HRSA) 
 — Indian Health Service (IHS) 
 — Substance Abuse and Mental Health Services   
 Administration (SAMHSA)
 — National Institutes of Health (NIH): 
 – National Institute on Alcohol Abuse 
  and Alcoholism (NIAAA) 
 – National Institute of Child Health 
  and Human Development (NICHD) 
______________________________________________
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The Interagency Coordinating Committee on Fetal 
Alcohol Syndrome (ICCFAS) was created in October 
of 1996, in response to a report by an expert committee 
of the Institute of Medicine (IOM). The IOM report is 
entitled Fetal Alcohol Syndrome: Diagnosis, Epidemiology, 
Prevention, and Treatment (Stratton et al., 1996). The report 
recommended that the National Institute on Alcohol Abuse 
and Alcoholism (NIAAA) chair a federal effort to coordinate 
fetal alcohol syndrome (FAS) activities, because the 
responsibility for addressing the many issues relevant to FAS 
transcends the mission and resources of any single agency or 
program. The ICCFAS is chaired by a member of the Senior 
Staff of the NIAAA. 
The mission of the ICCFAS is to enhance and increase 
communication, cooperation, collaboration, and partnerships 
among disciplines and federal agencies to address health, 
education, developmental disabilities, alcohol research, and 
health and social services and justice issues that are relevant 
to disorders caused by prenatal alcohol exposure. The themes 
around which the ICCFAS bases the foundation of its current 
work are: (1) prevention of drinking during pregnancy; (2) 
intervening with children and families affected by prenatal 
alcohol exposure; (3) improving methods for diagnosis and 
case identification; (4) increasing research on etiology and 
pathogenesis; and (5) increasing information dissemination. 
The vision of ICCFAS is that collaborative partnerships, 
using the resources of governmental and other organizations, 
will reduce the prevalence of individuals affected by prenatal 
exposure to alcohol, provide appropriate interventions and 
support to persons affected by fetal alcohol spectrum disorders 
(FASD) and their families, and build sustainable approaches 
within existing systems to properly address the disorders.
Communication, collaboration, and cooperation are fostered 
and promoted among ICCFAS members through meetings, 
informal discussions, and the overall exchange of ideas and 
updates of new findings and activities in conversations and 
electronic missives. Strategies on how activities in different 
agencies can complement each other and how synergy can be 
achieved are the primary focus of these exchanges. Leveraging 
the work of member organizations through more collaborative 
and cooperative activities is a key strategy. The concept of 
distributed leadership is used to increase cooperation and 
collaboration within the ICCFAS agencies on projects of 
mutual interest. 
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The member organizations have diverse missions and unique 
strengths. Some generate new knowledge through research 
funding. Other agencies fund translational research that 
feeds back to promote basic research. Others promote and 
assist in the development and improvement of health care 
delivery services by states and community organizations. 
One of the guiding principles of the ICCFAS has been to 
use the diverse missions, strengths, and resources of the 
various member organizations to advance the effectiveness 
of the federal response to alcohol-related birth defects. The 
ICCFAS implements its policy of shared leadership through 
use of subcommittees and working groups led by different 
agencies to help set direction and apprise the ICCFAS of new 
opportunities for action in specific areas. 
The ICCFAS Work Groups (subcommittees) address special 
issues and implementation of planned activities. Work Groups 
allow the membership of the ICCFAS to work with a lead 
agency and some outside experts to plan and develop actions 
on a specific issue. The Work Groups are usually composed 
of several members of the ICCFAS and/other representatives 
from member federal agencies, and six or seven individuals 
who are knowledgeable about FASD but are not part of the 
U.S. government. A broad perspective and balance on the 
ICCFAS Work Groups is assured by including biomedical 
researchers, physicians and other service providers, educators, 
FASD advocates, and other interested and knowledgeable 
persons. In FY2007 there were three ICCFAS Work Groups: 
ICCFAS Work Group on Women, Drinking, and Pregnancy; 
ICCFAS Work Group on Juvenile Justice Issues; and the 
ICCFAS Education Work Group. 
Check the ICCFAS web page at the NIAAA website for 
information on current membership, links to members’ 
websites, current activities, meeting summaries, resource 
materials, proceedings of conferences, and progress reports. 
For more information, see:
http://www.niaaa.nih.gov/AboutNIAAA/InterAgency/
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